Targeting GABA-A for the Treatment of Social Disability in Young Adults With Autism Spectrum Disorders: A Phase II Proof of Mechanism Trial

NCT01966679 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

40

Enrollment

OTHER

Sponsor class

Conditions

Autism Spectrum Disorder

Interventions

DRUG: AZD7325
DRUG: Placebo

Sponsor

University of California, Los Angeles